Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Examining the effectiveness of involuntary treatment for individuals with substance use disorders (SUDs).
Ressources
Lit review | 2023
Evidence base, Policy/Regulatory
To describe the sociodemographic characteristics of a cohort of people who use methamphetamine with a history of hospitalizations in London, Ontario, including their substance use patterns, health
Original research | 2023
Stimulants, Hospitals, About PWUD
Commentary | 2023
Substitution/OAT, About prescribers, Clinical guidance, Policy/Regulatory, Hesitancy of prescribers
To compare time on treatment among individuals initiating buprenorphine/naloxone and methadone and understand how retention varies according to age, sex, and urban/rural residence.
Original research | 2023
Substitution/OAT, Transitions in care/treatment, Rural/remote, Sex/Gender , About PWUD, Outcomes
The purpose of this systematic scoping review is to: 1) review published curricula on harm reduction for substance use implemented by undergraduate (UME) and graduate medical education (GME) in the
Scoping review | 2023
Harm reduction, About prescribers, Clinical guidance
Commentary | 2023
About prescribers, Clinical guidance
To identify the association of benzodiazepine discontinuation with mortality and other adverse events among patients prescribed stable long-term benzodiazepine therapy, stratified by baseline
Original research | 2023
Mortality, Outcomes, Transitions in care/treatment
Guidelines | 2023
Stimulants, About prescribers, Clinical guidance
Fatal overdoses involving fentanyl/fentanyl analogs (F/FA) have increased in the US, raising questions about naloxone doses for F/FA overdose reversal.
Original research | 2023
Overdose
Responding to increasing rates of illicit drug toxicity mortality in British Columbia, regional health authorities introduced various types and models of drug checking services starting in 2016.
Original research | 2023
Drug checking, Barriers and enablers, About PWUD
Commentary | 2023
Overdose, Mortality
The objective of this study was to identify and describe perceptions of fentanyl among African Americans who misuse opioids, while capturing their motivations for seeking out or avoiding fentanyl.
Original research | 2023
Equity, About PWUD
We aimed to evaluate how the number of new safer supply hydromorphone (SSHM) dispensations changed during the pandemic in Ontario.
Original research | 2023
Safer supply, About prescribers
Report | 2023
Equity, Decriminalization/legalization, Harm reduction, About PWUD
This research comprised a qualitative study that explored the motivations, effects and toxicity of novel synthetic opioids from the perspectives of Tweeters.
Original research | 2023
About PWUD, Illegal drugs
We aim to assess the rate and factors associated with treatment access among individuals with high-risk substance use.
Original research | 2023
About PWUD, Transitions in care/treatment
This study aims to investigate factors associated with reported experience of opioid overdose in the prior six months using survey data from British Columbia, Canada from 2018, 2019, and 2021.
Original research | 2023
Overdose, Housing, Sex/Gender , About PWUD
Archived webinar | 2023
Clinical guidance, About prescribers
Infographic | 2023
Substitution/OAT, Transitions in care/treatment, Hospitals
The study objectives were to evaluate opioid agonist therapy (OAT) initiation rates after a hospital encounter for opioid toxicity in Ontario, Canada, and determine whether publication of a 2018 Ca
Original research | 2023
Hospitals, Transitions in care/treatment, Substitution/OAT
